| 1 | v | 6,879 |
| 2 | v. | 1,300 |
| 3 | / | 889 |
| 4 | * | 449 |
| 5 | f5 | 55 |
| 6 | arene | 42 |
| 7 | o2max | 36 |
| 8 | nav | 28 |
| 9 | p90 | 27 |
| 10 | penta | 27 |
| 11 | 1/ | 24 |
| 12 | … | 24 |
| 13 | r.h. | 20 |
| 14 | v/s | 18 |
| 15 | -point | 15 |
| 16 | -ve | 14 |
| 17 | isoxazol-3-yl | 13 |
| 18 | bubalis | 12 |
| 19 | f3-f4 | 12 |
| 20 | c/ | 10 |
| 21 | /- | 9 |
| 22 | flumethrin | 9 |
| 23 | /hctz | 8 |
| 24 | auc0 | 8 |
| 25 | e-stained | 8 |
| 26 | idic | 8 |
| 27 | macrogard | 8 |
| 28 | mod-cho | 8 |
| 29 | o2peak | 8 |
| 30 | 2407 | 7 |
| 31 | platyrhynchos | 7 |
| 32 | δef | 7 |
| 33 | ,4 | 6 |
| 34 | 7/48 | 6 |
| 35 | avaps | 6 |
| 36 | chirocaine | 6 |
| 37 | ci- | 6 |
| 38 | ifcc | 6 |
| 39 | υ | 6 |
| 40 | -diacetylmidecamycin | 5 |
| 41 | /48 | 5 |
| 42 | 3175 | 5 |
| 43 | ago-ovar | 5 |
| 44 | cd1c | 5 |
| 45 | f0-f2 | 5 |
| 46 | hashish | 5 |
| 47 | plitidepsin | 5 |
| 48 | pseudacris | 5 |
| 49 | spidweighted | 5 |
| 50 | v11 | 5 |
| 51 | β-cit | 5 |
| 52 | *h | 4 |
| 53 | ,0 | 4 |
| 54 | ,2 | 4 |
| 55 | -se | 4 |
| 56 | 17/41 | 4 |
| 57 | 1984-1987 | 4 |
| 58 | 3/6he | 4 |
| 59 | dilt | 4 |
| 60 | equivalents/day | 4 |
| 61 | faza | 4 |
| 62 | i-5 | 4 |
| 63 | i/p | 4 |
| 64 | indom | 4 |
| 65 | iodophenyl | 4 |
| 66 | non-ergot-derived | 4 |
| 67 | oxf | 4 |
| 68 | p300+tens | 4 |
| 69 | p600+tens | 4 |
| 70 | pavon | 4 |
| 71 | pianli | 4 |
| 72 | plusmn | 4 |
| 73 | post-kno | 4 |
| 74 | tanita | 4 |
| 75 | '-sulfo-alpha-d-quinovopyranosyl | 3 |
| 76 | +/-4.4 | 3 |
| 77 | -site | 3 |
| 78 | 27.29 | 3 |
| 79 | 2×/week | 3 |
| 80 | 49d | 3 |
| 81 | a-85380 | 3 |
| 82 | a= | 3 |
| 83 | alexandre | 3 |
| 84 | crecca | 3 |
| 85 | deltapp | 3 |
| 86 | dose/h | 3 |
| 87 | eqr | 3 |
| 88 | hept-4-en-2-one | 3 |
| 89 | i2= | 3 |
| 90 | icnh | 3 |
| 91 | m+e | 3 |
| 92 | maggi | 3 |
| 93 | mass/bsa | 3 |
| 94 | mgg | 3 |
| 95 | nnas | 3 |
| 96 | p=3 | 3 |
| 97 | penicillin-nonsusceptible | 3 |
| 98 | polymer/mb-tf | 3 |
| 99 | quinazolin-6-yl | 3 |
| 100 | r-tfa | 3 |
| 101 | recoleta | 3 |
| 102 | ssk | 3 |
| 103 | stop-go | 3 |
| 104 | -01 | 2 |
| 105 | -1,3-benzothiazole | 2 |
| 106 | -monophosphatase | 2 |
| 107 | -o-α-l-rhamnosyl | 2 |
| 108 | -s- | 2 |
| 109 | -terpyridine-κ | 2 |
| 110 | -terthiophene | 2 |
| 111 | /annum | 2 |
| 112 | /topiramate | 2 |
| 113 | 0.80-1.38 | 2 |
| 114 | 1.00- | 2 |
| 115 | 1.5.6 | 2 |
| 116 | 12.7- | 2 |
| 117 | 2008-march | 2 |
| 118 | 24/161 | 2 |
| 119 | 3,603 | 2 |
| 120 | 73/75 | 2 |
| 121 | 79/87 | 2 |
| 122 | addiqol | 2 |
| 123 | anerdian | 2 |
| 124 | assessor-only | 2 |
| 125 | audax | 2 |
| 126 | blood-xu | 2 |
| 127 | clypeata | 2 |
| 128 | dextrobupivacaine | 2 |
| 129 | equibiaxial | 2 |
| 130 | friom | 2 |
| 131 | gusto-2b | 2 |
| 132 | gxp | 2 |
| 133 | hirundo | 2 |
| 134 | ldl-iva | 2 |
| 135 | lv-syn-eff-g4bs-syn-tetoff | 2 |
| 136 | mandarinia | 2 |
| 137 | mgcfa | 2 |
| 138 | nanotheranostic | 2 |
| 139 | newtom | 2 |
| 140 | oi6 | 2 |
| 141 | pei-cmk-3 | 2 |
| 142 | penfill | 2 |
| 143 | phyglovas | 2 |
| 144 | polymer/mb | 2 |
| 145 | predvo | 2 |
| 146 | pringle-time | 2 |
| 147 | pva-cmk-3 | 2 |
| 148 | pyrimidine-2,4-diamine | 2 |
| 149 | quinhon | 2 |
| 150 | scalpfix | 2 |
| 151 | svettis® | 2 |
| 152 | tcp-ti | 2 |
| 153 | v/ | 2 |
| 154 | vivasight | 2 |
| 155 | webwatch | 2 |
| 156 | ≥20/20 | 2 |
| 157 | '-dialkylquarterthiophene | 1 |
| 158 | '-didodecyl-quaterthiophene | 1 |
| 159 | '-e-caffeoylglucopyranosyl | 1 |
| 160 | '-o-acetyl-beta-d-glucopyranosyl-beta-d-glucopyranoside | 1 |
| 161 | '-o-e-feruloyl | 1 |
| 162 | +/-15.5 | 1 |
| 163 | +/-6.8 | 1 |
| 164 | +dpn | 1 |
| 165 | -1.186 | 1 |
| 166 | -14.606- | 1 |
| 167 | -2,2':5',3 | 1 |
| 168 | -3cis | 1 |
| 169 | -7h | 1 |
| 170 | -9.584- | 1 |
| 171 | -acetyl | 1 |
| 172 | -angeloyloxy-beta-d-fucopyranosyl | 1 |
| 173 | -bi/fe | 1 |
| 174 | -dimethoxy-galloyl | 1 |
| 175 | -dimethylpyrano | 1 |
| 176 | -disulfatoglucuronide | 1 |
| 177 | -epigallocatechin+ | 1 |
| 178 | -gum | 1 |
| 179 | -o-acetylrhamnosyl | 1 |
| 180 | -o-galloyl | 1 |
| 181 | -o-galloyl-β-d-glucopyranosyl | 1 |
| 182 | -o-malonyl-beta-glucopyranoside | 1 |
| 183 | -o-rhamnosylswertisin | 1 |
| 184 | -terpyridine-3'-carboxamide | 1 |
| 185 | -terthienyl | 1 |
| 186 | -toxic | 1 |
| 187 | -trans-p-coumaroyl | 1 |
| 188 | -trihydroxybutyl | 1 |
| 189 | -variants | 1 |
| 190 | -α-l-ramnopyranoside | 1 |
| 191 | .801 | 1 |
| 192 | 1.30- | 1 |
| 193 | 12/ecog | 1 |
| 194 | 1q21.1q21.2 | 1 |
| 195 | 1was | 1 |
| 196 | 2-amino-5-bromo-6-methyl-4-pyrimidinol | 1 |
| 197 | 2-glasses-solutions | 1 |
| 198 | 21/ | 1 |
| 199 | 26.4-≤ | 1 |
| 200 | 3,3'-dihydroxyisorenieratene | 1 |
| 201 | 3-hydroxynonanoate | 1 |
| 202 | 3-morpholinosyndnomine | 1 |
| 203 | 3-n-methylamino-1- | 1 |
| 204 | 3.833- | 1 |
| 205 | 39× | 1 |
| 206 | 45.8+/- | 1 |
| 207 | 49.2+/- | 1 |
| 208 | 723.0± | 1 |
| 209 | 86ef | 1 |
| 210 | 86wmsi | 1 |
| 211 | :1.67 | 1 |
| 212 | :164 | 1 |
| 213 | :3,4 | 1 |
| 214 | alfacon1 | 1 |
| 215 | bidan | 1 |
| 216 | bokhoor | 1 |
| 217 | bw*ht | 1 |
| 218 | c-β-d-xylopyranoside-2-hydroxy-propane | 1 |
| 219 | carbohydrate-caffeine-electrolyte | 1 |
| 220 | chlorotrimethylsilane | 1 |
| 221 | ci,2.0-11.2 | 1 |
| 222 | ci-18.9 | 1 |
| 223 | ci=0.04,0.25 | 1 |
| 224 | ci=0.25,58.09 | 1 |
| 225 | ci=3.1 | 1 |
| 226 | coastcross | 1 |
| 227 | conophora | 1 |
| 228 | copra | 1 |
| 229 | credible-interval | 1 |
| 230 | deaths/heat | 1 |
| 231 | dextran-70 | 1 |
| 232 | dimethyl-para-toluidine | 1 |
| 233 | dimethylacetmide | 1 |
| 234 | drgoniometry | 1 |
| 235 | dynamat | 1 |
| 236 | dīn | 1 |
| 237 | edv-t1 | 1 |
| 238 | ee- | 1 |
| 239 | efetuado | 1 |
| 240 | efs/survival | 1 |
| 241 | ethylendiaminetetraacetic | 1 |
| 242 | fibrinolysis-alone | 1 |
| 243 | formulations-diprivan | 1 |
| 244 | getmyrom | 1 |
| 245 | ha2aar/ha3ar= | 1 |
| 246 | henning | 1 |
| 247 | huisartspraktijken | 1 |
| 248 | ics-from | 1 |
| 249 | inkabab | 1 |
| 250 | interfant | 1 |
| 251 | l-lys·so | 1 |
| 252 | lafe | 1 |
| 253 | lafeo | 1 |
| 254 | lagartos-el | 1 |
| 255 | lamb-producing | 1 |
| 256 | linpro | 1 |
| 257 | lys·so | 1 |
| 258 | maxspid | 1 |
| 259 | maxvas-spid | 1 |
| 260 | maxvas-totpar | 1 |
| 261 | mcl-3-hydroxyalkanoates | 1 |
| 262 | metlos | 1 |
| 263 | mvc∙s | 1 |
| 264 | nafookh | 1 |
| 265 | nashooq | 1 |
| 266 | nicotinamide-phospholipidic | 1 |
| 267 | npv/ppv | 1 |
| 268 | o40 | 1 |
| 269 | opec/ojec | 1 |
| 270 | paragonix | 1 |
| 271 | parakeets | 1 |
| 272 | pf™ | 1 |
| 273 | phosphoinositide-3,5-bisphosphate | 1 |
| 274 | placebo/lower-dose | 1 |
| 275 | polidocanol-foam | 1 |
| 276 | poliotm | 1 |
| 277 | post-b/t | 1 |
| 278 | proadifen | 1 |
| 279 | r-product | 1 |
| 280 | saiseikai | 1 |
| 281 | shamoom | 1 |
| 282 | st-affymetrix | 1 |
| 283 | sulfated-beta-cyclodextrin | 1 |
| 284 | thidiazuron | 1 |
| 285 | tris-borate | 1 |
| 286 | units±2.2 | 1 |
| 287 | vs.21.72 | 1 |
| 288 | wire-compatible | 1 |
| 289 | wiron | 1 |
| 290 | xt-compatible | 1 |
| 291 | ±5.31 | 1 |
| 292 | αω | 1 |
| 293 | ≥20/18 | 1 |
| 294 | ］ | 1 |
| 1 | '-dialkylquarterthiophene | 1 |
| 2 | '-didodecyl-quaterthiophene | 1 |
| 3 | '-e-caffeoylglucopyranosyl | 1 |
| 4 | '-o-acetyl-beta-d-glucopyranosyl-beta-d-glucopyranoside | 1 |
| 5 | '-o-e-feruloyl | 1 |
| 6 | '-sulfo-alpha-d-quinovopyranosyl | 3 |
| 7 | * | 449 |
| 8 | *h | 4 |
| 9 | +/-15.5 | 1 |
| 10 | +/-4.4 | 3 |
| 11 | +/-6.8 | 1 |
| 12 | +dpn | 1 |
| 13 | ,0 | 4 |
| 14 | ,2 | 4 |
| 15 | ,4 | 6 |
| 16 | -01 | 2 |
| 17 | -1,3-benzothiazole | 2 |
| 18 | -1.186 | 1 |
| 19 | -14.606- | 1 |
| 20 | -2,2':5',3 | 1 |
| 21 | -3cis | 1 |
| 22 | -7h | 1 |
| 23 | -9.584- | 1 |
| 24 | -acetyl | 1 |
| 25 | -angeloyloxy-beta-d-fucopyranosyl | 1 |
| 26 | -bi/fe | 1 |
| 27 | -diacetylmidecamycin | 5 |
| 28 | -dimethoxy-galloyl | 1 |
| 29 | -dimethylpyrano | 1 |
| 30 | -disulfatoglucuronide | 1 |
| 31 | -epigallocatechin+ | 1 |
| 32 | -gum | 1 |
| 33 | -monophosphatase | 2 |
| 34 | -o-acetylrhamnosyl | 1 |
| 35 | -o-galloyl | 1 |
| 36 | -o-galloyl-β-d-glucopyranosyl | 1 |
| 37 | -o-malonyl-beta-glucopyranoside | 1 |
| 38 | -o-rhamnosylswertisin | 1 |
| 39 | -o-α-l-rhamnosyl | 2 |
| 40 | -point | 15 |
| 41 | -s- | 2 |
| 42 | -se | 4 |
| 43 | -site | 3 |
| 44 | -terpyridine-3'-carboxamide | 1 |
| 45 | -terpyridine-κ | 2 |
| 46 | -terthienyl | 1 |
| 47 | -terthiophene | 2 |
| 48 | -toxic | 1 |
| 49 | -trans-p-coumaroyl | 1 |
| 50 | -trihydroxybutyl | 1 |
| 51 | -variants | 1 |
| 52 | -ve | 14 |
| 53 | -α-l-ramnopyranoside | 1 |
| 54 | .801 | 1 |
| 55 | / | 889 |
| 56 | /- | 9 |
| 57 | /48 | 5 |
| 58 | /annum | 2 |
| 59 | /hctz | 8 |
| 60 | /topiramate | 2 |
| 61 | 0.80-1.38 | 2 |
| 62 | 1.00- | 2 |
| 63 | 1.30- | 1 |
| 64 | 1.5.6 | 2 |
| 65 | 1/ | 24 |
| 66 | 12.7- | 2 |
| 67 | 12/ecog | 1 |
| 68 | 17/41 | 4 |
| 69 | 1984-1987 | 4 |
| 70 | 1q21.1q21.2 | 1 |
| 71 | 1was | 1 |
| 72 | 2-amino-5-bromo-6-methyl-4-pyrimidinol | 1 |
| 73 | 2-glasses-solutions | 1 |
| 74 | 2008-march | 2 |
| 75 | 21/ | 1 |
| 76 | 24/161 | 2 |
| 77 | 2407 | 7 |
| 78 | 26.4-≤ | 1 |
| 79 | 27.29 | 3 |
| 80 | 2×/week | 3 |
| 81 | 3,3'-dihydroxyisorenieratene | 1 |
| 82 | 3,603 | 2 |
| 83 | 3-hydroxynonanoate | 1 |
| 84 | 3-morpholinosyndnomine | 1 |
| 85 | 3-n-methylamino-1- | 1 |
| 86 | 3.833- | 1 |
| 87 | 3/6he | 4 |
| 88 | 3175 | 5 |
| 89 | 39× | 1 |
| 90 | 45.8+/- | 1 |
| 91 | 49.2+/- | 1 |
| 92 | 49d | 3 |
| 93 | 7/48 | 6 |
| 94 | 723.0± | 1 |
| 95 | 73/75 | 2 |
| 96 | 79/87 | 2 |
| 97 | 86ef | 1 |
| 98 | 86wmsi | 1 |
| 99 | :1.67 | 1 |
| 100 | :164 | 1 |
| 101 | :3,4 | 1 |
| 102 | a-85380 | 3 |
| 103 | a= | 3 |
| 104 | addiqol | 2 |
| 105 | ago-ovar | 5 |
| 106 | alexandre | 3 |
| 107 | alfacon1 | 1 |
| 108 | anerdian | 2 |
| 109 | arene | 42 |
| 110 | assessor-only | 2 |
| 111 | auc0 | 8 |
| 112 | audax | 2 |
| 113 | avaps | 6 |
| 114 | bidan | 1 |
| 115 | blood-xu | 2 |
| 116 | bokhoor | 1 |
| 117 | bubalis | 12 |
| 118 | bw*ht | 1 |
| 119 | c-β-d-xylopyranoside-2-hydroxy-propane | 1 |
| 120 | c/ | 10 |
| 121 | carbohydrate-caffeine-electrolyte | 1 |
| 122 | cd1c | 5 |
| 123 | chirocaine | 6 |
| 124 | chlorotrimethylsilane | 1 |
| 125 | ci,2.0-11.2 | 1 |
| 126 | ci- | 6 |
| 127 | ci-18.9 | 1 |
| 128 | ci=0.04,0.25 | 1 |
| 129 | ci=0.25,58.09 | 1 |
| 130 | ci=3.1 | 1 |
| 131 | clypeata | 2 |
| 132 | coastcross | 1 |
| 133 | conophora | 1 |
| 134 | copra | 1 |
| 135 | crecca | 3 |
| 136 | credible-interval | 1 |
| 137 | deaths/heat | 1 |
| 138 | deltapp | 3 |
| 139 | dextran-70 | 1 |
| 140 | dextrobupivacaine | 2 |
| 141 | dilt | 4 |
| 142 | dimethyl-para-toluidine | 1 |
| 143 | dimethylacetmide | 1 |
| 144 | dose/h | 3 |
| 145 | drgoniometry | 1 |
| 146 | dynamat | 1 |
| 147 | dīn | 1 |
| 148 | e-stained | 8 |
| 149 | edv-t1 | 1 |
| 150 | ee- | 1 |
| 151 | efetuado | 1 |
| 152 | efs/survival | 1 |
| 153 | eqr | 3 |
| 154 | equibiaxial | 2 |
| 155 | equivalents/day | 4 |
| 156 | ethylendiaminetetraacetic | 1 |
| 157 | f0-f2 | 5 |
| 158 | f3-f4 | 12 |
| 159 | f5 | 55 |
| 160 | faza | 4 |
| 161 | fibrinolysis-alone | 1 |
| 162 | flumethrin | 9 |
| 163 | formulations-diprivan | 1 |
| 164 | friom | 2 |
| 165 | getmyrom | 1 |
| 166 | gusto-2b | 2 |
| 167 | gxp | 2 |
| 168 | ha2aar/ha3ar= | 1 |
| 169 | hashish | 5 |
| 170 | henning | 1 |
| 171 | hept-4-en-2-one | 3 |
| 172 | hirundo | 2 |
| 173 | huisartspraktijken | 1 |
| 174 | i-5 | 4 |
| 175 | i/p | 4 |
| 176 | i2= | 3 |
| 177 | icnh | 3 |
| 178 | ics-from | 1 |
| 179 | idic | 8 |
| 180 | ifcc | 6 |
| 181 | indom | 4 |
| 182 | inkabab | 1 |
| 183 | interfant | 1 |
| 184 | iodophenyl | 4 |
| 185 | isoxazol-3-yl | 13 |
| 186 | l-lys·so | 1 |
| 187 | lafe | 1 |
| 188 | lafeo | 1 |
| 189 | lagartos-el | 1 |
| 190 | lamb-producing | 1 |
| 191 | ldl-iva | 2 |
| 192 | linpro | 1 |
| 193 | lv-syn-eff-g4bs-syn-tetoff | 2 |
| 194 | lys·so | 1 |
| 195 | m+e | 3 |
| 196 | macrogard | 8 |
| 197 | maggi | 3 |
| 198 | mandarinia | 2 |
| 199 | mass/bsa | 3 |
| 200 | maxspid | 1 |
| 201 | maxvas-spid | 1 |
| 202 | maxvas-totpar | 1 |
| 203 | mcl-3-hydroxyalkanoates | 1 |
| 204 | metlos | 1 |
| 205 | mgcfa | 2 |
| 206 | mgg | 3 |
| 207 | mod-cho | 8 |
| 208 | mvc∙s | 1 |
| 209 | nafookh | 1 |
| 210 | nanotheranostic | 2 |
| 211 | nashooq | 1 |
| 212 | nav | 28 |
| 213 | newtom | 2 |
| 214 | nicotinamide-phospholipidic | 1 |
| 215 | nnas | 3 |
| 216 | non-ergot-derived | 4 |
| 217 | npv/ppv | 1 |
| 218 | o2max | 36 |
| 219 | o2peak | 8 |
| 220 | o40 | 1 |
| 221 | oi6 | 2 |
| 222 | opec/ojec | 1 |
| 223 | oxf | 4 |
| 224 | p300+tens | 4 |
| 225 | p600+tens | 4 |
| 226 | p90 | 27 |
| 227 | p=3 | 3 |
| 228 | paragonix | 1 |
| 229 | parakeets | 1 |
| 230 | pavon | 4 |
| 231 | pei-cmk-3 | 2 |
| 232 | penfill | 2 |
| 233 | penicillin-nonsusceptible | 3 |
| 234 | penta | 27 |
| 235 | pf™ | 1 |
| 236 | phosphoinositide-3,5-bisphosphate | 1 |
| 237 | phyglovas | 2 |
| 238 | pianli | 4 |
| 239 | placebo/lower-dose | 1 |
| 240 | platyrhynchos | 7 |
| 241 | plitidepsin | 5 |
| 242 | plusmn | 4 |
| 243 | polidocanol-foam | 1 |
| 244 | poliotm | 1 |
| 245 | polymer/mb | 2 |
| 246 | polymer/mb-tf | 3 |
| 247 | post-b/t | 1 |
| 248 | post-kno | 4 |
| 249 | predvo | 2 |
| 250 | pringle-time | 2 |
| 251 | proadifen | 1 |
| 252 | pseudacris | 5 |
| 253 | pva-cmk-3 | 2 |
| 254 | pyrimidine-2,4-diamine | 2 |
| 255 | quinazolin-6-yl | 3 |
| 256 | quinhon | 2 |
| 257 | r-product | 1 |
| 258 | r-tfa | 3 |
| 259 | r.h. | 20 |
| 260 | recoleta | 3 |
| 261 | saiseikai | 1 |
| 262 | scalpfix | 2 |
| 263 | shamoom | 1 |
| 264 | spidweighted | 5 |
| 265 | ssk | 3 |
| 266 | st-affymetrix | 1 |
| 267 | stop-go | 3 |
| 268 | sulfated-beta-cyclodextrin | 1 |
| 269 | svettis® | 2 |
| 270 | tanita | 4 |
| 271 | tcp-ti | 2 |
| 272 | thidiazuron | 1 |
| 273 | tris-borate | 1 |
| 274 | units±2.2 | 1 |
| 275 | v | 6,879 |
| 276 | v. | 1,300 |
| 277 | v/ | 2 |
| 278 | v/s | 18 |
| 279 | v11 | 5 |
| 280 | vivasight | 2 |
| 281 | vs.21.72 | 1 |
| 282 | webwatch | 2 |
| 283 | wire-compatible | 1 |
| 284 | wiron | 1 |
| 285 | xt-compatible | 1 |
| 286 | ±5.31 | 1 |
| 287 | αω | 1 |
| 288 | β-cit | 5 |
| 289 | δef | 7 |
| 290 | υ | 6 |
| 291 | … | 24 |
| 292 | ≥20/18 | 1 |
| 293 | ≥20/20 | 2 |
| 294 | ］ | 1 |
| 1 | * | 449 |
| 2 | -epigallocatechin+ | 1 |
| 3 | /- | 9 |
| 4 | 49.2+/- | 1 |
| 5 | 45.8+/- | 1 |
| 6 | 1.00- | 2 |
| 7 | 1.30- | 1 |
| 8 | 3-n-methylamino-1- | 1 |
| 9 | 3.833- | 1 |
| 10 | -9.584- | 1 |
| 11 | -14.606- | 1 |
| 12 | 12.7- | 2 |
| 13 | ee- | 1 |
| 14 | ci- | 6 |
| 15 | -s- | 2 |
| 16 | r.h. | 20 |
| 17 | v. | 1,300 |
| 18 | / | 889 |
| 19 | 1/ | 24 |
| 20 | 21/ | 1 |
| 21 | c/ | 10 |
| 22 | v/ | 2 |
| 23 | ,0 | 4 |
| 24 | ≥20/20 | 2 |
| 25 | o40 | 1 |
| 26 | dextran-70 | 1 |
| 27 | a-85380 | 3 |
| 28 | p90 | 27 |
| 29 | auc0 | 8 |
| 30 | ci=3.1 | 1 |
| 31 | -01 | 2 |
| 32 | .801 | 1 |
| 33 | v11 | 5 |
| 34 | ±5.31 | 1 |
| 35 | 17/41 | 4 |
| 36 | 24/161 | 2 |
| 37 | alfacon1 | 1 |
| 38 | edv-t1 | 1 |
| 39 | ,2 | 4 |
| 40 | ci,2.0-11.2 | 1 |
| 41 | 1q21.1q21.2 | 1 |
| 42 | units±2.2 | 1 |
| 43 | vs.21.72 | 1 |
| 44 | f0-f2 | 5 |
| 45 | -2,2':5',3 | 1 |
| 46 | pva-cmk-3 | 2 |
| 47 | pei-cmk-3 | 2 |
| 48 | 3,603 | 2 |
| 49 | p=3 | 3 |
| 50 | ,4 | 6 |
| 51 | :3,4 | 1 |
| 52 | +/-4.4 | 3 |
| 53 | :164 | 1 |
| 54 | f3-f4 | 12 |
| 55 | i-5 | 4 |
| 56 | +/-15.5 | 1 |
| 57 | ci=0.04,0.25 | 1 |
| 58 | 73/75 | 2 |
| 59 | 3175 | 5 |
| 60 | f5 | 55 |
| 61 | 1.5.6 | 2 |
| 62 | -1.186 | 1 |
| 63 | oi6 | 2 |
| 64 | 2407 | 7 |
| 65 | :1.67 | 1 |
| 66 | 79/87 | 2 |
| 67 | 1984-1987 | 4 |
| 68 | +/-6.8 | 1 |
| 69 | ≥20/18 | 1 |
| 70 | 0.80-1.38 | 2 |
| 71 | /48 | 5 |
| 72 | 7/48 | 6 |
| 73 | ci-18.9 | 1 |
| 74 | ci=0.25,58.09 | 1 |
| 75 | 27.29 | 3 |
| 76 | i2= | 3 |
| 77 | a= | 3 |
| 78 | ha2aar/ha3ar= | 1 |
| 79 | crecca | 3 |
| 80 | mgcfa | 2 |
| 81 | r-tfa | 3 |
| 82 | mandarinia | 2 |
| 83 | conophora | 1 |
| 84 | copra | 1 |
| 85 | mass/bsa | 3 |
| 86 | clypeata | 2 |
| 87 | recoleta | 3 |
| 88 | tanita | 4 |
| 89 | penta | 27 |
| 90 | ldl-iva | 2 |
| 91 | faza | 4 |
| 92 | gusto-2b | 2 |
| 93 | inkabab | 1 |
| 94 | polymer/mb | 2 |
| 95 | cd1c | 5 |
| 96 | ifcc | 6 |
| 97 | opec/ojec | 1 |
| 98 | idic | 8 |
| 99 | nicotinamide-phospholipidic | 1 |
| 100 | ethylendiaminetetraacetic | 1 |
| 101 | nanotheranostic | 2 |
| 102 | -toxic | 1 |
| 103 | 49d | 3 |
| 104 | e-stained | 8 |
| 105 | spidweighted | 5 |
| 106 | non-ergot-derived | 4 |
| 107 | maxvas-spid | 1 |
| 108 | maxspid | 1 |
| 109 | macrogard | 8 |
| 110 | m+e | 3 |
| 111 | -terpyridine-3'-carboxamide | 1 |
| 112 | dimethylacetmide | 1 |
| 113 | -disulfatoglucuronide | 1 |
| 114 | -o-malonyl-beta-glucopyranoside | 1 |
| 115 | '-o-acetyl-beta-d-glucopyranosyl-beta-d-glucopyranoside | 1 |
| 116 | -α-l-ramnopyranoside | 1 |
| 117 | -bi/fe | 1 |
| 118 | lafe | 1 |
| 119 | 3/6he | 4 |
| 120 | wire-compatible | 1 |
| 121 | xt-compatible | 1 |
| 122 | penicillin-nonsusceptible | 3 |
| 123 | -1,3-benzothiazole | 2 |
| 124 | pringle-time | 2 |
| 125 | chlorotrimethylsilane | 1 |
| 126 | c-β-d-xylopyranoside-2-hydroxy-propane | 1 |
| 127 | -terthiophene | 2 |
| 128 | '-didodecyl-quaterthiophene | 1 |
| 129 | '-dialkylquarterthiophene | 1 |
| 130 | arene | 42 |
| 131 | 3,3'-dihydroxyisorenieratene | 1 |
| 132 | dextrobupivacaine | 2 |
| 133 | chirocaine | 6 |
| 134 | dimethyl-para-toluidine | 1 |
| 135 | pyrimidine-2,4-diamine | 2 |
| 136 | 3-morpholinosyndnomine | 1 |
| 137 | hept-4-en-2-one | 3 |
| 138 | fibrinolysis-alone | 1 |
| 139 | alexandre | 3 |
| 140 | -se | 4 |
| 141 | -monophosphatase | 2 |
| 142 | placebo/lower-dose | 1 |
| 143 | phosphoinositide-3,5-bisphosphate | 1 |
| 144 | /topiramate | 2 |
| 145 | 3-hydroxynonanoate | 1 |
| 146 | tris-borate | 1 |
| 147 | -site | 3 |
| 148 | carbohydrate-caffeine-electrolyte | 1 |
| 149 | -ve | 14 |
| 150 | 86ef | 1 |
| 151 | δef | 7 |
| 152 | lv-syn-eff-g4bs-syn-tetoff | 2 |
| 153 | polymer/mb-tf | 3 |
| 154 | oxf | 4 |
| 155 | mgg | 3 |
| 156 | lamb-producing | 1 |
| 157 | henning | 1 |
| 158 | 12/ecog | 1 |
| 159 | *h | 4 |
| 160 | dose/h | 3 |
| 161 | -7h | 1 |
| 162 | 2008-march | 2 |
| 163 | webwatch | 2 |
| 164 | nafookh | 1 |
| 165 | icnh | 3 |
| 166 | hashish | 5 |
| 167 | saiseikai | 1 |
| 168 | maggi | 3 |
| 169 | pianli | 4 |
| 170 | 86wmsi | 1 |
| 171 | tcp-ti | 2 |
| 172 | o2peak | 8 |
| 173 | 2×/week | 3 |
| 174 | ssk | 3 |
| 175 | equibiaxial | 2 |
| 176 | efs/survival | 1 |
| 177 | credible-interval | 1 |
| 178 | lagartos-el | 1 |
| 179 | penfill | 2 |
| 180 | 2-amino-5-bromo-6-methyl-4-pyrimidinol | 1 |
| 181 | addiqol | 2 |
| 182 | isoxazol-3-yl | 13 |
| 183 | quinazolin-6-yl | 3 |
| 184 | iodophenyl | 4 |
| 185 | -terthienyl | 1 |
| 186 | -o-galloyl | 1 |
| 187 | -dimethoxy-galloyl | 1 |
| 188 | '-o-e-feruloyl | 1 |
| 189 | -trans-p-coumaroyl | 1 |
| 190 | -angeloyloxy-beta-d-fucopyranosyl | 1 |
| 191 | -o-galloyl-β-d-glucopyranosyl | 1 |
| 192 | '-e-caffeoylglucopyranosyl | 1 |
| 193 | '-sulfo-alpha-d-quinovopyranosyl | 3 |
| 194 | -o-α-l-rhamnosyl | 2 |
| 195 | -o-acetylrhamnosyl | 1 |
| 196 | -acetyl | 1 |
| 197 | -trihydroxybutyl | 1 |
| 198 | polidocanol-foam | 1 |
| 199 | indom | 4 |
| 200 | friom | 2 |
| 201 | shamoom | 1 |
| 202 | ics-from | 1 |
| 203 | getmyrom | 1 |
| 204 | newtom | 2 |
| 205 | poliotm | 1 |
| 206 | -gum | 1 |
| 207 | /annum | 2 |
| 208 | bidan | 1 |
| 209 | anerdian | 2 |
| 210 | formulations-diprivan | 1 |
| 211 | proadifen | 1 |
| 212 | huisartspraktijken | 1 |
| 213 | -diacetylmidecamycin | 5 |
| 214 | flumethrin | 9 |
| 215 | sulfated-beta-cyclodextrin | 1 |
| 216 | -o-rhamnosylswertisin | 1 |
| 217 | plitidepsin | 5 |
| 218 | plusmn | 4 |
| 219 | quinhon | 2 |
| 220 | wiron | 1 |
| 221 | thidiazuron | 1 |
| 222 | pavon | 4 |
| 223 | +dpn | 1 |
| 224 | dīn | 1 |
| 225 | efetuado | 1 |
| 226 | hirundo | 2 |
| 227 | lafeo | 1 |
| 228 | stop-go | 3 |
| 229 | mod-cho | 8 |
| 230 | -dimethylpyrano | 1 |
| 231 | post-kno | 4 |
| 232 | linpro | 1 |
| 233 | lys·so | 1 |
| 234 | l-lys·so | 1 |
| 235 | predvo | 2 |
| 236 | i/p | 4 |
| 237 | deltapp | 3 |
| 238 | gxp | 2 |
| 239 | nashooq | 1 |
| 240 | maxvas-totpar | 1 |
| 241 | ago-ovar | 5 |
| 242 | bokhoor | 1 |
| 243 | eqr | 3 |
| 244 | v/s | 18 |
| 245 | nnas | 3 |
| 246 | phyglovas | 2 |
| 247 | 1was | 1 |
| 248 | mcl-3-hydroxyalkanoates | 1 |
| 249 | -3cis | 1 |
| 250 | bubalis | 12 |
| 251 | pseudacris | 5 |
| 252 | p300+tens | 4 |
| 253 | p600+tens | 4 |
| 254 | 2-glasses-solutions | 1 |
| 255 | platyrhynchos | 7 |
| 256 | metlos | 1 |
| 257 | avaps | 6 |
| 258 | coastcross | 1 |
| 259 | parakeets | 1 |
| 260 | -variants | 1 |
| 261 | mvc∙s | 1 |
| 262 | post-b/t | 1 |
| 263 | deaths/heat | 1 |
| 264 | dynamat | 1 |
| 265 | r-product | 1 |
| 266 | bw*ht | 1 |
| 267 | vivasight | 2 |
| 268 | β-cit | 5 |
| 269 | dilt | 4 |
| 270 | interfant | 1 |
| 271 | -point | 15 |
| 272 | blood-xu | 2 |
| 273 | v | 6,879 |
| 274 | nav | 28 |
| 275 | npv/ppv | 1 |
| 276 | audax | 2 |
| 277 | o2max | 36 |
| 278 | scalpfix | 2 |
| 279 | paragonix | 1 |
| 280 | st-affymetrix | 1 |
| 281 | equivalents/day | 4 |
| 282 | assessor-only | 2 |
| 283 | drgoniometry | 1 |
| 284 | /hctz | 8 |
| 285 | υ | 6 |
| 286 | αω | 1 |
| 287 | 39× | 1 |
| 288 | pf™ | 1 |
| 289 | 26.4-≤ | 1 |
| 290 | … | 24 |
| 291 | svettis® | 2 |
| 292 | 723.0± | 1 |
| 293 | -terpyridine-κ | 2 |
| 294 | ］ | 1 |